Growth hormone values after an oral glucose load do not add clinically useful information in patients with acromegaly on long-term somatostatin receptor ligand treatment

Endocrine

Volumn 45, Issue 1, 2014, Pages 122-127

  Reimondo, Giuseppe ^a   Bondanelli, Marta ^b   Ambrosio, Maria Rosaria ^b   Grimaldi, Franco ^c   Zaggia, Barbara ^a   Zatelli, Maria Chiara ^b   Allasino, Barbara ^a   Laino, Federica ^a   Aroasio, Emiliano ^f   Termine, Angela ^a   Conton, Pierantonio ^d   Paoletta, Agostino ^e   Demenis, Ernesto ^d   Uberti, Ettore Degli ^b   Terzolo, Massimo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^d Ospedale Civile di Montebelluna   (Italy)

^e Dipartimento di Endocrinologia e Diabetologia   (Italy)

^f SAN LUIGI GONZAGA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Acromegaly; GH after OGTT; GH random; IGF I; Somatostatin analogs

Indexed keywords

GLUCOSE; GROWTH HORMONE; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

ACROMEGALY; ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYNDROME DELINEATION; VERY ELDERLY; YOUNG ADULT;

ACROMEGALY; ADULT; AGED; AGED, 80 AND OVER; BLOOD CHEMICAL ANALYSIS; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84895907760     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-9996-9     Document Type: Article

References (24)

1. S. Melmed, A. Colao, A. Barkan, M. Molitch, A.B. Grossman, D. Kleinberg, D. Clemmons, P. Chanson, E. Laws, J. Schlechte, M.L. Vance, K. Ho, A. Giustina, Guidelines for acromegaly management: an update. J. Clin. Endocrinol. Metab. 94(5), 1509-1517 (2009)
2. A. Giustina, A. Barkan, F.F. Casanueva, F. Cavagnini, L. Frohman, K. Ho, J. Veldhuis, J. Wass, K. Von Werder, S. Melmed, Criteria for cure of acromegaly: a consensus statement. J. Clin. Endocrinol. Metab. 85(2), 526-529 (2000)
3. A. Giustina, P. Chanson, M.D. Bronstein, A. Klibanski, S. Lamberts, F.F. Casanueva, P. Trainer, E. Ghigo, K. Ho, S. Melmed, A consensus on criteria for cure of acromegaly. J. Clin. Endocrinol. Metab. 95(7), 3141-3148 (2010)
4. A.M. Arafat, M. Mohlig, M.O. Weickert, F.H. Perschel, J. Purschwitz, J. Spranger, C.J. Strasburger, C. Schofl, A.F. Pfeiffer, Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index. J. Clin. Endocrinol. Metab. 93(4), 1254-1262 (2008)
5. A. Colao, R. Pivonello, L.M. Cavallo, M. Gaccione, R.S. Auriemma, F. Esposito, P. Cappabianca, G. Lombardi, Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly. Clin. Endocrinol. (Oxf) 65(2), 250-256 (2006)
6. I.M. Holdaway, M.J. Bolland, G.D. Gamble, A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur. J. Endocrinol. 159(2), 89-95 (2008)
7. R. Kauppinen-Makelin, T. Sane, A. Reunanen, M.J. Valimaki, L. Niskanen, H. Markkanen, E. Loyttyniemi, T. Ebeling, P. Jaatinen, H. Laine, P. Nuutila, P. Salmela, J. Salmi, U.H. Stenman, J. Viikari, E. Voutilainen, A nationwide survey of mortality in acromegaly. J. Clin. Endocrinol. Metab. 90(7), 4081-4086 (2005)
8. N.R. Biermasz, F.W. Dekker, A.M. Pereira, S.W. van Thiel, P.J. Schutte, H. van Dulken, J.A. Romijn, F. Roelfsema, Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements. J. Clin. Endocrinol. Metab. 89(6), 2789-2796 (2004)
9. P.U. Freda, Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant? Clin. Endocrinol. (Oxf) 71(2), 166-170 (2009)
10. O. Serri, C. Beauregard, J. Hardy, Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly. J. Clin. Endocrinol. Metab. 89(2), 658-661 (2004)
11. J.D. Carmichael, V.S. Bonert, J.M. Mirocha, S. Melmed, The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly. J. Clin. Endocrinol. Metab. 94(2), 523-527 (2009)
12. M. Scacchi, C. Carzaniga, G. Vitale, L.M. Fatti, F. Pecori Giraldi, M. Andrioli, A. Cattaneo, F. Cavagnini, Assessment of biochemical control of acromegaly during treatment with somatostatin analogues by oral glucose load and insulin-like growth factor I. J. Endocrinol. Invest. 34(9), e291-e295 (2010)
13. G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, G. Germano, G. Grassi, A.M. Heagerty, S.E. Kjeldsen, S. Laurent, K. Narkiewicz, L. Ruilope, A. Rynkiewicz, R.E. Schmieder, H.A. Boudier, A. Zanchetti, A. Vahanian, J. Camm, R. De Caterina, V. Dean, K. Dickstein, G. Filippatos, C. Funck-Brentano, I. Hellemans, S.D. Kristensen, K. McGregor, U. Sechtem, S. Silber, M. Tendera, P. Widimsky, J.L. Zamorano, S. Erdine, W. Kiowski, E. Agabiti-Rosei, E. Ambrosioni, L.H. Lindholm, M. Viigimaa, S. Adamopoulos, V. Bertomeu, D. Clement, C. Farsang, D. Gaita, G. Lip, J.M. Mallion, A.J. Manolis, P.M. Nilsson, E. O'Brien, P. Ponikowski, J. Redon, F. Ruschitzka, J. Tamargo, P. van Zwieten, B. Waeber, B. Williams, 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 25(6), 1105-1187 (2007)
14. American Diabetes Association, Standards of medical care in diabetes-2009. Diabetes Care 32(Suppl 1), S13-S61 (2009)
15. A. Muller, M. Scholz, O. Blankenstein, G. Binder, R. Pfaffle, A. Korner, W. Kiess, A. Heider, M. Bidlingmaier, J. Thiery, J. Kratzsch, Harmonization of growth hormone measurements with different immunoassays by data adjustment. Clin. Chem. Lab. Med. 49(7), 1135-1142 (2011)
16. M. Bidlingmaier, P.U. Freda, Measurement of human growth hormone by immunoassays: current status, unsolved problems and clinical consequences. Growth Horm. IGF Res. 20(1), 19-25 (2009)
17. N. Karavitaki, A. Fernandez, V. Fazal-Sanderson, J.A. Wass, The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegaly. Clin. Endocrinol. (Oxf) 71(6), 840-845 (2009)
18. R. Cozzi, R. Attanasio, S. Grottoli, G. Pagani, P. Loli, V. Gasco, A.M. Pedroncelli, M. Montini, E. Ghigo, Treatment of acromegaly with SS analogues: should GH and IGF-I target levels be lowered to assert a tight control of the disease? J. Endocrinol. Invest. 27(11), 1040-1047 (2004)
19. E.O. Machado, G.F. Taboada, L.V. Neto, F.R. van Haute, L.L. Correa, G.A. Balarini, Y. Shrank, M. Goulart, M.R. Gadelha, Prevalence of discordant GH and IGF-I levels in acromegalics at diagnosis, after surgical treatment and during treatment with octreotide LAR. Growth Horm. IGF Res. 18(5), 389-393 (2008)
20. R.D. Murray, K. Kim, S.G. Ren, M. Chelly, Y. Umehara, S. Melmed, Central and peripheral actions of somatostatin on the growth hormone-IGF-I axis. J. Clin. Invest. 114(3), 349-356 (2004)
21. A. Bianchi, A. Giustina, V. Cimino, R. Pola, F. Angelini, A. Pontecorvi, L. De Marinis, Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly. J. Clin. Endocrinol. Metab. 94(6), 2015-2022 (2009)
22. L. Cazabat, J.C. Souberbielle, P. Chanson, Dynamic tests for the diagnosis and assessment of treatment efficacy in acromegaly. Pituitary 11(2), 129-139 (2008)
23. A. Giustina, T. Mancini, P.F. Boscani, E. de Menis, E. degli Uberti, E. Ghigo, F. Martino, A. Colao, Assessment of the awareness and management of cardiovascular complications of acromegaly in Italy. The COM.E.T.A. (COMorbidities Evaluation and Treatment in Acromegaly) Study. J. Endocrinol. Invest. 31(8), 731-738 (2008)
24. A. Colao, D. Ferone, P. Marzullo, G. Lombardi, Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr. Rev. 25(1), 102-152 (2004)